1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Prostate Cancer Nuclear Medicine Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Prostate Cancer Nuclear Medicine Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Prostate Cancer Nuclear Medicine Market Regional Analysis
6.2 Middle East & Africa Prostate Cancer Nuclear Medicine Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Prostate Cancer Nuclear Medicine Market Forecast Analysis
7. Middle East & Africa Prostate Cancer Nuclear Medicine Market Analysis – by Type
7.1 PET
- 7.1.1 Overview
- 7.1.2 PET: Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 SPECT
- 7.2.1 Overview
- 7.2.2 SPECT: Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Middle East & Africa Prostate Cancer Nuclear Medicine Market Analysis – by PET Product
8.1 F-18
- 8.1.1 Overview
- 8.1.2 F-18: Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 C-11
- 8.2.1 Overview
- 8.2.2 C-11: Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Ga68-PSMA
- 8.3.1 Overview
- 8.3.2 Ga68-PSMA: Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Middle East & Africa Prostate Cancer Nuclear Medicine Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Middle East & Africa Prostate Cancer Nuclear Medicine Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa
- 10.2.1 Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 South Africa:
Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by Type
- 10.2.1.1.2 South Africa: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
- 10.2.1.1.3 South Africa: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by End User
- 10.2.1.2 Saudi Arabia:
Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by Type
- 10.2.1.2.2 Saudi Arabia: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
- 10.2.1.2.3 Saudi Arabia: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by End User
- 10.2.1.3 UAE:
Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 UAE: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by Type
- 10.2.1.3.2 UAE: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
- 10.2.1.3.3 UAE: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by End User
- 10.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by Type
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Prostate Cancer Nuclear Medicine Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 ImaginAb
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Curium
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 ABX advanced biochemical compounds GmbH
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Telix Pharmaceuticals Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Novartis AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Lantheus Medical Imaging, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Middle East & Africa Prostate Cancer Nuclear Medicine Market
